Division (1) Matters for decision (doc. NC2708Ea)X1
United Kingdom
- (a)
Annexes A/1 and C/1 – Classification of new INN products (List 120). The Union shall approve the 125 classifications (HS 2017 Edition) and the three consequential reclassifications (HS 2022 Edition) recommended by the Scientific Sub-Committee.
- (b)
Annexes A/2 and C/2 – Classification of new INN products (List 121). The Union shall approve the 143 classifications (HS 2017 Edition) and the 15 consequential reclassifications (HS 2022 Edition) recommended by the Scientific Sub-Committee.
- (c)
Annexes A/3 and C/3 – Possible reclassification of certain INN products consequential upon the Article 16 Recommendation of 23 June 2019 . The Union shall approve the consequential (HS 2022 Edition) reclassifications of the 143 INN products agreed to by the Scientific Sub-Committee.
- (d)
Annexes B/1 and C/6 – Decisions taken by the HS Committee at its 63rd and 64th Sessions and the WCO Council at its 133rd/134th Sessions, affecting the work of the Scientific Sub-Committee. The Union shall approve the reclassifications of ‘ zilucoplan ’ and ‘ etryptamine ’ agreed by the Scientific Sub-Committee, in subheadings 2933.79 and 2939.80, respectively.
The Union shall agree to all proposed classifications as they are in line with the current classification policy in the Union.